GF Investments is a leading global asset management firm with a strong focus on healthcare investments. Founded in 2012, GF Investments has rapidly grown to manage over $5 billion in assets across private equity, venture capital, hedge funds and public equities. Its healthcare investment team consists of experienced investment professionals with deep domain expertise in both the US and China healthcare markets. GF Investments Healthcare Funds I & II have delivered top-quartile performance by successfully investing in innovative biotech and medtech companies. The firm’s China healthcare investments benefit from its local presence and partnerships in Shanghai, Beijing and Hong Kong.
GF Investments Has an Experienced Healthcare Investment Team with Strong Track Record
GF Investments’ healthcare investment team is led by Dr. Yingying Chen who has over 20 years of experience in healthcare investment banking and research. Before joining GF Investments, Dr. Chen held senior roles in healthcare investment banking at UBS, RBS and ABN AMRO. She also did pharmaceutical research at Pfizer’s R&D center. The GF healthcare team includes investment professionals with both scientific and financial backgrounds. Together they have invested and managed over $2 billion in 40+ healthcare companies across various subsectors like biotech, medical devices and healthcare services. GF Healthcare Fund I has generated a net IRR of 25% by investing in 15 healthcare companies before 2017. GF Healthcare Fund II has also produced top quartile returns so far by investing in innovative biotech companies developing new cancer immunotherapies and gene therapies.
GF Investments Leverages Its China Presence and Connections for Healthcare Investments
China presents tremendous healthcare investment opportunities driven by an aging population, increasing prevalence of chronic diseases, expanding healthcare infrastructure, and supportive government policies. GF Investments opened its Shanghai office in 2015 dedicated to covering the healthcare sector. The China healthcare investment team includes returnee professionals educated and previously worked in the US, allowing GF Investments to bridge between the two healthcare markets. GF Investments’ Partners Healthcare Fund focuses on cross-border investment opportunities to bring innovative therapies and technologies to meet unmet medical needs in China. It has invested in 10 China-based healthcare companies and achieved above market returns by leveraging its local presence and connections.
GF Investments Adopts a Rigorous Investment Approach Optimized for the Volatile Healthcare Sector
Unlike other sectors, healthcare investing requires deep scientific expertise and experience to understand complex innovations and assess clinical and regulatory risks inherent in drug and device development. GF Investments has developed a disciplined investment process tailored for the healthcare industry. Its scientific advisory board of Key Opinion Leaders provides insights on new innovations and trends in medical practice. The investment team conducts in-depth due diligence including speaking with scientists, doctors and regulators to evaluate the technical/clinical merits and risks of each investment. Portfolio companies are actively monitored and guided by GF’s seasoned partners throughout their growth cycle. While the healthcare sector is often volatile, GF’s rigorous investment approach has allowed its healthcare funds to consistently outperform healthcare VC/PE benchmarks.
GF Investments Brings Together Global Expertise and Local Execution for Successful Healthcare Investing
GF Investments has demonstrated the ability to generate superior returns in healthcare investing through its global expertise and local execution capabilities: 1) A specialized healthcare investment team with complementary scientific, medical and financial experience. 2) Access to top-tier healthcare deals in both the US and Greater China markets via its broad industry network. 3) Local China presence to identify emerging opportunities and hands-on value creation. 4) Disciplined investment process tailored for complex healthcare deals. 5) Focus on innovative but proven technologies and veteran management teams. 6) Hands-on approach in guiding portfolio companies through clinical trials, regulatory approvals and commercialization. 7) Ability to syndicate investments with an extensive LP network. GF Investments is well positioned as a leading healthcare specialist investor for the future.
In summary, GF Investments is a leading healthcare focused investment firm with an experienced investment team and successful track record. Its global expertise, local China presence, rigorous healthcare specialized investment process and hands-on approach in value creation enable GF Investments to capitalize on healthcare innovation and achieve attractive risk-adjusted returns.